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Abstract
Background: Hydrogen sulfide (H2S), a gaseous mediator plays an important role in a wide range
of physiological and pathological processes. H2S has been extensively studied for its various roles
in cardiovascular and neurological disorders. However, the role of H2S in inflammation is still
controversial. The current study was aimed to investigate the therapeutic potential of sodium
hydrosulfide (NaHS), an H2S donor in in vivo model of acute pancreatitis in mice.
Methods: Acute pancreatitis was induced in mice by hourly caerulein injections (50 μg/kg) for 10
hours. Mice were treated with different dosages of NaHS (5 mg/kg, 10 mg/kg or 15 mg/kg) or with
vehicle, distilled water (DW). NaHS or DW was administered 1 h before induction of pancreatitis.
Mice were sacrificed 1 h after the last caerulein injection. Blood, pancreas and lung tissues were
collected and were processed to measure the plasma amylase, myeloperoxidase (MPO) activities
in pancreas and lung and chemokines and adhesion molecules in pancreas and lung.
Results: It was revealed that significant reduction of inflammation, both in pancreas and lung was
associated with NaHS 10 mg/kg. Further the anti-inflammatory effects of NaHS 10 mg/kg were
associated with reduction of pancreatic and pulmonary inflammatory chemokines and adhesion
molecules. NaHS 5 mg/kg did not cause significant improvement on inflammation in pancreas and
associated lung injury and NaHS 15 mg/kg did not further enhance the beneficial effects seen with
NaHS 10 mg/kg.
Conclusion: In conclusion, these data provide evidence for anti-inflammatory effects of H2S based
on its dosage used.
Background
Hydrogen sulphide (H2S) a novel gaseous messenger, is
synthesized endogenously from L-cysteine by two pyri-
doxal-5'-phosphate-dependent enzymes, cystathionine β-
synthetase (CBS, EC4.2.1.22) and cystathionine γ-lyase
(CSE, EC4.4.1.1). Both CBS and CSE are widely distrib-
uted in tissues. However, CBS is the predominant source
of H2S in the central nervous system whereas CSE is the
major H2S-producing enzyme in the cardiovascular sys-
tem. H2S dilates blood vessels and relaxes gastrointestinal
smooth muscles by opening muscle KATP channels and
promotes hippocampal long-term potentiation by
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enhancing the sensitivity of N-methyl-D-aspartate recep-
tors to glutamate [1,2].
Since the discovery of endogenous H2S, many studies
have been performed to understand the physiologic and
pathologic roles of this gas and numerous animal studies
have shown its beneficial effects especially in cardiovascu-
lar disorders [2]. However the role of H2S in inflamma-
tion is only recently beginning to emerge and the exact
role of H2S in inflammation is still not very clearly under-
stood. Research studies have shown pro-inflammatory
effects of H2S in various models of inflammation. In those
models of inflammation plasma H2S level, tissue H2S syn-
thesizing enzyme activity and CSE expression were
increased and inhibition of H2S synthesis by DL-propar-
gylglycine (PAG) treatments reduced the inflammation
[3-8]. In addition, some studies have also reported anti-
inflammatory effects of H2S. Treatments with either H2S
releasing non steroidal anti-inflammatory drugs (e.g. s-
diclofenac, ATB-429) or with H2S donors (e.g. sodium
hydrosulfide, Lawesson's reagent or N-acetylcysteine)
have demonstrated anti-inflammatory activity in various
models of inflammation [9-15]. Recent studies have also
shown biphasic dose response of H2S in inflammation. In
myocardial ischemia reperfusion injury, treatment with
different doses of H2S ranging from (10-500 μg/kg)
revealed U shaped dose response curve. In this study, sig-
nificant reduction of infarct size was observed in mice
received 50 μg/kg [16]. In another study of myocardial
ischemia reperfusion injury, similar effect of H2S was
observed. Post conditioning with exogenous sodium
hydrosulfide (NaHS) treatment (0.1 to 10 μM) produced
a concentration-dependent limitation of infarct. How-
ever, NaHS (100 μM) did not decrease the infarct size
[17].
In the present study we investigated therapeutic potential
of sodium hydrosulfide (NaHS), an H2S donor in in vivo
model of acute pancreatitis in mice.
Methods
Experimental procedures
All animal experiments were approved by the Animal
Ethic Committee of National University of Singapore and
were carried out in accordance with established Interna-
tional Guiding Principles for Animal Research). Swiss
mice (male, 20-25 g) were used and maintained in the
Animal Housing Unit in an environment with controlled
temperature (21-24°C) and lighting (12:12 h light-dark-
ness cycle). Standard laboratory chow and drinking water
were provided ad libitum. A period of at least 2 days was
allowed for the animals to acclimatize before any experi-
mental procedures were undertaken.
Induction of acute pancreatitis
Caerulein was obtained from Bachem (Bubendorf, Swit-
zerland) and NaHS was obtained from Sigma-Aldrich
(USA). Mice were randomly assigned to control or exper-
imental groups using 10 animals for each group. Animals
were given hourly intraperitoneal (i.p.) injections of nor-
mal saline (saline control group) or saline containing
caerulein (50 μg/kg) over 10 hours [4,10]. Groups of ani-
mal were treated either with different doses of NaHS (5
mg/kg, 10 mg/kg or 15 mg/kg) dissolved in distilled water
(DW), or with only DW (vehicle). NaHS or DW was given
i.p. one hour before the first caerulein injection. One hour
after the last caerulein injection animals were sacrificed by
an i.p. injection of a lethal dose of pentobarbital (50 mg/
kg: Nembutal, CEVA Sante Animale, Naaldwijk, Nether-
lands). Blood, pancreas and lung tissues were collected.
Harvested heparinized blood was centrifuged (10,000
rpm, 10 min, 4°C) and the plasma was aspirated and
stored at -80°C for subsequent detection of plasma amy-
lase. Samples of pancreas and lung were weighed, snap
frozen in liquid nitrogen and then stored at -80°C for sub-
sequent measurement of tissue myeloperoxidase (MPO)
activities, chemokines and adhesion molecules as
described in detail below. Parts of the pancreas and lung
were also fixed in 10% vol/vol neutral phosphate-buff-
ered formalin for more than 48 h and then were processed
for histology.
Amylase estimation
Plasma amylase activity was measured using a kinetic
spectrophotometric assay. Plasma samples were incu-
bated with the Amylase reagent (Sigma, St. Louis, Mo) for
2 min at 37°C, and absorbance was measured every
minute for the subsequent 2 min at 405 nm using manu-
facturers' instructions [4,10]. The resulting change in
absorbance was used to calculate the amylase activity.
MPO estimation
Inflammatory cells sequestration in pancreas and lung
were quantified by measuring tissue MPO activity [4,10].
Tissue samples were thawed, homogenized in 20 mM
phosphate buffer (pH 7.4), centrifuged (13,000 rpm, 10
min, 4-C), and the resulting pellet resuspended in 50 mM
phosphate buffer (pH 6.0) containing 0.5% wt/vol hexa-
decyltrimethylammonium bromide (Sigma). The suspen-
sion was subjected to four cycles of freezing and thawing
and further disrupted by sonication (40 s). The sample
was then centrifuged (13,000 rpm, 5 min, 4-C), and the
supernatant was used for the MPO assay. The sample was
mixed with equal volume of 1-component tetramethyl-
benzidine (TMB) substrate (Sureblue), incubated for a
fixed time, and then terminated by equal volume of 2N
H2SO4. The absorbance was measured at 450 nm and cor-
rected for the calculated DNA [18] of the tissue sample.Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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Results were expressed as enzyme activity (fold increase
over corresponding saline injected control groups).
Morphological examination
Paraffin-embedded pancreas and lung samples were sec-
tioned (5 μm), stained with hematoxylin/eosin (H and E)
and were examined with light microscopy.
Enzyme-linked immunosorbent assay (ELISA) analysis of 
chemokines and adhesion molecules
The levels of chemokines (CCL2, CCL3 and CXCL1) and
adhesion molecules (E- and P-selectins, ICAM-1, and
VCAM-1) were measured in pancreas and lung tissue
homogenate by a sandwich ELISA using DuoSet ELISA
kits. Briefly, an anti-chemokine//adhesion molecule pri-
mary antibodies were coated onto 96- well ELISA plates
and incubated overnight at room temperature. Samples
and standards were added to the wells and incubated for
2 h, the wells were washed, and a biotinylated goat anti-
mouse chemokine/adhesion molecule antibodies were
added for 2 h. Plates were washed again, and streptavidin
antibodies conjugated to HRP were added for 20 min.
After a further wash, TMB was added for color develop-
ment, and the reaction was terminated with 2 N H2SO4.
Absorbance was measured at 450 nm. Sample concentra-
tion was estimated from the standard curve. The sample
concentration was then corrected for the DNA content of
the tissue [18].
Statistical analysis
All values were expressed as mean ± S.E.M. The signifi-
cance of changes was evaluated by using ANOVA when
comparing three or more groups and Tukey and/or LSD
method were used as a post hoc test for comparison
among different groups. A P value of < 0.05 was consid-
ered to indicate a significant difference.
Results
Effect of different dosages of NaHS on plasma amylase in 
caerulein-induced acute pancreatitis
In our initial studies, groups of mice (n = 10) were treated
with different dosages of NaHS (N5 mg/kg, N10 mg/kg
and N15 mg/kg). NaHS was administered 1 h before the
caerulein induced pancreatitis. Effects of NaHS were com-
pared with the group of mice (n = 10) treated with only
DW (vehicle) 1 h before the caerulein induced pancreati-
tis. As shown in Fig. 1, mice pretreated with vehicle or
with NaHS followed by hourly caerulein injections, pan-
creatitis was manifested by significant rise in plasma amy-
lase activity compared to mice injected with hourly saline
only (P < 0.05). However within the NaHS group, signifi-
cant reduction of plasma amylase compared to vehicle
pretreated mice was not associated with mice received
NaHS either 5 mg/kg or 15 mg/kg and a small but signifi-
cant reduction of plasma amylase activity was observed
only in mice received NaHS 10 mg/kg (P < 0.05).
Effect of different dosages of NaHS on pancreas MPO in 
caerulein-induced acute pancreatitis
Further pancreatic injury was assessed by measuring pan-
creatic myeloperoxidase (MPO) activity and histology.
Measurement of MPO enzyme which is located in
azurophile granules of neutrophils and monocytes reflects
inflammatory cells infiltration in tissue. There was a sig-
nificant MPO increase in mice received vehicle/or various
dosages of NaHS compared to saline CTRL group (Fig.
2A). However within the NaHS treated groups, only mice
pretreated with NaHS 10 mg/kg had significant reduction
of MPO activity as compared with vehicle treated mice
(Fig. 2A). Further histological examination of pancreas
sections of vehicle pre-treated mice show clear evidence of
oedema, destruction of histoarchitecture of the acini and
infiltration of inflammatory cells (Fig. 2B, ii). However
within the NaHS groups (Fig. 2B, iii, iv and 2B, v) mice
received NaHS 10 mg/kg had a significant reduction of
edema and inflammatory cells compared to vehicle pre-
treated mice (Fig. 2B, iv).
Effect of different dosages of NaHS on acute pancreatitis-
associated lung injury
Acute pancreatitis, in mice pretreated with DW, followed
by 10 hourly injections of caerulein (50 μg/kg) was asso-
ciated with lung injury. As shown in Fig. 3A caerulein-
induced acute pancreatitis was associated with a signifi-
cant rise in lung MPO activity, indicating the presence of
sequestered inflammatory cells. Histological examination
Effect of NaHS treatment on plasma amylase activity Figure 1
Effect of NaHS treatment on plasma amylase activ-
ity. Acute pancreatitis was induced by intraperitoneal admin-
istration of caerulein ((50 μg/kg, hourly for 10 h). Column 
labeled 'CTRL' refers to plasma amylase activity in mice 
injected intraperitoneal saline (not caerulein) as control. Col-
umn labeled 'Veh+Cae', 'N5+Cae', 'N10+Cae', 'N15+Cae' 
refers pretreatment with vehicle (DW) or different dosages 
of NaHS (5 mg/kg, 10 mg/kg or 15 mg/kg respectively) admin-
istered intraperitoneal 1 h before the first injection of caer-
ulein. Results shown are the mean ± SEM for 8-10 animals in 
each group. Asterisk (*): P < 0.05 c.f. CTRL group. Asterisk 
(#): P < 0.05 c.f. (Veh + Cae) group. Abbreviations used: 
CTRL: Control; Cae: Caerulein; Veh: Vehicle; N: NaHS.Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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A: Effect of NaHS treatment on pancreatic myeloperoxidase (MPO) Figure 2
A: Effect of NaHS treatment on pancreatic myeloperoxidase (MPO). Acute pancreatitis was induced by intraperito-
neal administration of caerulein ((50 μg/kg hourly, for 10 h). Column labeled 'CTRL' refers to pancreas MPO activity in mice 
injected intraperitoneal saline (not caerulein) as control. Column labeled 'Veh+Cae', 'N5+Cae', 'N10+Cae', 'N15+Cae' refers 
pretreatment with vehicle or different dosages of NaHS (5 mg/kg, 10 mg/kg or 15 mg/kg respectively) administered intraperito-
neal 1 h before the first injection of caerulein. Results shown are the mean ± SEM for 8-10 animals in each group. Asterisk (*): 
P < 0.05 c.f. CTRL group. Asterisk (#): P < 0.05 c.f. (Veh + Cae) group. Abbreviations used: CTRL: Control; Cae: Caerulein; 
Veh: Vehicle; N: NaHS. B. Pancreas histology: i, Control (saline injected) pancreas; ii, caerulein-induced pancreatitis pretreated 
with DW (vehicle) only; arrow showing oedema, and infiltration of inflammatory cells. iii, pretreated with NaHS (5 mg/kg);iv, 
pretreated with NaHS (10 mg/kg); v, pretreated with NaHS (15 mg/kg).Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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Effect of NaHS treatment on pancreatitis associated lung injury in acute pancreatitis Figure 3
Effect of NaHS treatment on pancreatitis associated lung injury in acute pancreatitis. A. MPO activity in lung. 
Acute pancreatitis was induced by intraperitoneal administration of caerulein ((50 μg/kg hourly, for 10 h). Column labeled 
'CTRL' refers to lung MPO activity in mice injected intraperitoneal saline (not caerulein) as control. Column labeled 'Veh+Cae', 
'N5+Cae', 'N10+Cae', 'N15+Cae' refers pretreatment with vehicle or different dosages of NaHS (5 mg/kg, 10 mg/kg or 15 mg/
kg respectively) administered intraperitoneal 1 h before the first injection of caerulein. Results shown are the mean ± SEM for 
8-10 animals in each group. Asterisk (*): P < 0.05 c.f. control (saline) group. Asterisk (#): P < 0.05 c.f. (Veh + Cae) group. 
Abbreviations used: CTRL: Control; Cae: Caerulein; Veh: Vehicle; N: NaHS. B. Lung Histology: i, Lung section from control 
(saline injected) animal; ii, Lung section from caerulein-induced pancreatitis pretreated with DW (vehicle) only; arrow showing 
alveolar thickening and inflammatory cells infiltration. iii, pretreated with NaHS (5 mg/kg);iv, pretreated with NaHS (10 mg/kg); 
v, pretreated with NaHS (15 mg/kg).Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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of lung sections further confirmed evidence of lung injury
in acute pancreatitis as evidenced by alveolar thickening
and abundance inflammatory cells infiltration (Fig. 3B,
ii). However group of mice pretreated with NaHS 10 mg/
kg had significant reduction of cellular infiltration as evi-
denced by lung MPO (Fig. 3A) and lung histology (Fig.
3B, iv), while such protection was not seen in groups of
mice pretreated with NaHS 5 mg/kg or 15 mg/kg (Fig. 3A
and Fig 3B, iii and v). Thus, treatment with NaHS10 mg/
kg, but not with 5 mg/kg or 15 mg/kg resulted in a marked
reduction in the severity of pancreatitis as well associated
lung injury.
Effect of NaHS 10 mg/kg on pancreatic and pulmonary 
chemokines
Chemokines, well known for their potent leukocyte-acti-
vating properties have been shown to be involved in the
pathophysiological process of experimental acute pancre-
atitis. Based on our initial data with different dosages of
NaHS, we decided to see if reduction of pancreatic and
pulmonary inflammation with NaHS 10 mg/kg has any
effect on chemokines and adhesion molecules levels in
pancreas and lung. As expected chemokines, Chemokine
(C-C motif) Ligand 2 (CCL2), Chemokine (C-C motif)
Ligand 3 (CCL3) and Chemokine (C-X-C motif) Ligand 1
(CXCL1) were significantly increased in pancreas as well
as lung tissue (Fig 4: A, B and 4C) in vehicle treated group.
However NaHS 10 mg/kg treatment significantly reduced
all pancreatic chemokines and pulmonary chemokines
except pulmonary CCL3 (Fig 4: A, B and 4C).
Effect of NaHS 10 mg/kg on pancreatic and pulmonary cell 
adhesion molecules
Pancreatic and pulmonary cell adhesion molecules E-
selectin (endothelial), P-selectin (platelet), Intercellular
Cell Adhesion Molecule -1 (ICAM-1) and Vascular Cell
Adhesion Molecule-1 (VCAM-1) were measured by ELISA.
They were significantly increased in both pancreas and
lung tissue (Fig 5: A, B, C and 5D) of mice pretreated with
vehicle, while NaHS 10 mg/kg significantly reduced all
pancreatic and pulmonary adhesion molecules except
pulmonary E-selectin (Fig 5: A, B, C and 5D).
Discussion
Hydrogen sulfide, like nitric oxide (NO) and carbon mon-
oxide (CO) is a biological active gas of interest to pharma-
cologist. Several recent publications have shown its
physiological/pathological contribution mainly in cardio-
vascular system (CVS) and central nervous system (CNS)
and its therapeutic potential in CVS and CNS disorders
[1,2]. However, its precise role and therapeutic applica-
tion in inflammatory disorders is still controversial. Exog-
enous administrations of H2S have shown either pro-
inflammatory or anti-inflammatory effects depending on
its formula, dose and disease model [5,6,9-15]. Recent
studies have also shown that exogenous NaHS adminis-
tration exerted biphasic therapeutic response [16,17]. The
present study was aimed to investigate the therapeutic
potential of exogenous NaHS (H2S donor) on caerulein-
induced acute pancreatitis. In our initial experiment when
the mice were treated with different dosages of NaHS (5
mg/kg, 10 mg/kg and 15 mg/kg) 1 h before caerulein-
induced acute pancreatitis, it was revealed that there was a
dose dependent reduction of plasma amylase (Fig. 1),
pancreatic inflammation as evidenced by pancreas MPO
and histology (Fig. 2A and 2B) and pulmonary inflamma-
tion, as evidenced by lung MPO and histology (Fig. 3A
and 2B) and a significant reduction of inflammation was
seen only in mice pretreated with NaHS 10 mg/kg (Fig. 1,
Fig. 2A and 2B iv, Fig. 3A and 3B iv). NaHS 15 mg/kg treat-
ment did not have any additional beneficial effect as seen
with 10 mg/kg, and on contrary there is a trend towards
increased inflammation as evidenced by pancreas and
lung MPO and histology (Fig. 2A and 2B v, Fig. 3A and 3B
v). Further in a separate experiment, mice treated with
NaHS 20 mg/kg dose, was associated with increase mor-
tality (experimental observation). Thus, there is a dose
dependent effect of NaHS but doses 15 mg/kg and more
are associated with toxic effects. Similar findings were also
observed by other group albeit in different models. Treat-
ment with H2S donor, Na2S in doses of (10-500 μg/kg) at
the time of reperfusion and study of infarct size per area-
at-risk (INF/AAR) revealed a U-shaped dose-response
curve. Mice receiving 50 μg/kg displayed significant reduc-
tion in infarct size. However there is increase in ratio of
INF/AAR when mice received 100 μg/kg or 500 μg/kg
[16]. Similarly in another study of ischemia-reperfusion
injury low physiological concentration NaHS (0.1-10 μM)
reduced the infarct size in a dose-dependent manner.
However high concentrate 100 μM NaHS increased the
infarct size [17]. Although both these models are very dif-
ferent from our model, similar to our study treatment
with different dosages of H2S donors Na2S or NaHS,
resulted in dose dependent reduction of infarct size or
inflammation and further increasing dose was not benefi-
cial at all. The narrow therapeutic window seen with our
results could be due to sudden release of H2S from H2S
donor like NaHS. NaHS is water soluble, resulting in
instant release of H2S upon injection and causing its toxic
effects.
Recruitment of various inflammatory cells like neu-
trophils, monocytes and macrophages to the inflamed/
injured tissues is mediated by chemokines. Chemokines
are a group of low-molecular-weight (8-10 kDa) polypep-
tides and are the key components of immune surveillance
[19]. We further investigated whether reduction of inflam-
matory cells infiltration in pancreas and lung was associ-
ated with any changes in chemokines. We investigated CC
chemokines such as CCL2 and CCL3 and CXC chemok-Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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Effect of NaHS treatment on pancreatic and pulmonary chemokines in acute pancreatitis Figure 4
Effect of NaHS treatment on pancreatic and pulmonary chemokines in acute pancreatitis. Acute pancreatitis was 
induced by intraperitoneal administration of caerulein ((50 μg/kg hourly, for 10 h). Column labeled CTRL' refers to chemokines 
level in mice injected intraperitoneal saline (not caerulein) as control. Column labeled 'Veh+Cae' and 'N10+Cae' refers pre-
treatment with vehicle or NaHS (10 mg/kg) administered intraperitoneal 1 h before the first injection of caerulein. Results 
shown are the mean ± SEM for 8-10 animals in each group. Asterisk (*): P < 0.05 c.f. control (saline) group. Asterisk (#): P < 
0.05 c.f. (Veh + Cae) group. Abbreviations used: CTRL: Control; Cae: Caerulein; Veh: Vehicle; N: NaHS.Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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Effect of NaHS treatment on pancreatic and pulmonary adhesion molecules Figure 5
Effect of NaHS treatment on pancreatic and pulmonary adhesion molecules. Acute pancreatitis was induced by 
intraperitoneal administration of caerulein ((50 μg/kg hourly, for 10 h). Column labeled 'CTRL' refers to adhesion molecules 
level in mice injected intraperitoneal saline (not caerulein) as control. Column labeled 'Veh+Cae' and 'N10+Cae' refers pre-
treatment with vehicle or NaHS (10 mg/kg) administered intraperitoneal 1 h before the first injection of caerulein. Results 
shown are the mean ± SEM for 8-10 animals in each group. Asterisk (*): P < 0.05 c.f. control (saline) group. Asterisk (#): P < 
0.05 c.f. (Veh + Cae) group. Abbreviations used: CTRL: Control; Cae: Caerulein; Veh: Vehicle; N: NaHS.Journal of Inflammation 2009, 6:35 http://www.journal-inflammation.com/content/6/1/35
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ines such as CXCL1. CCL2 and CCL3 exert strong chemo-
attractant effects on monocytes, macrophages, and lym-
phocytes. Recent studies have suggested that CCL2 is an
important inflammatory mediator during the early patho-
physiological process of AP and promotes distant organ
failure [20]. CXCL1 is a potent chemoattractant for poly-
morphonuclear neutrophils (PMN) and induces neu-
trophil degranulation and release of lysozyme, leading to
tissue damage. We found that our treatment with NaHS
10 mg/kg was associated with significant reduction of
pancreatic CCL2, CCL3 and CXCL1 as well as pulmonary
CCL2 and CXCL1 (Fig. 4). However there was no change
in pulmonary CCL3 with NaHS treatment (Fig. 4).
We also studied the effect of NaHS on the expression of
adhesion molecules in pancreas and lung. Substantial evi-
dence indicates that adhesion molecule expression is cru-
cial to the development and modulation of inflammatory
and immune processes. Vascular adhesion molecules are
important component in leukocyte rolling, adhesion and
trans-endothelial migration of inflammatory cells to the
site of tissue injury [19,21,22]. ICAM-1, VCAM-1, E-selec-
tin and P-selectin have been found to play an important
pro-inflammatory role in various models of acute pancre-
atitis [23,24]. In present study of acute pancreatitis also,
there was a significant increase of ICAM-1, VCAM-1, E-
selectin and P-selectin in mice pretreated with vehicle
confirming their pro-inflammatory role, while pretreat-
ment with NaHS 10 mg/kg caused significant reduction of
pancreatic ICAM-1, VCAM-1, E-selectin and P-selectin as
well as pulmonary ICAM-1, VCAM-1 and P-selectin (Fig.
5). There was no change in pulmonary E-selectin level
with NaHS pretreatment (Fig. 5) like pulmonary CCL3
(Fig. 4). These could be due to differential regulation of
inflammatory responses mediated by NaHS in pancreas
and lung.
Conclusions
In conclusion in this study of acute pancreatitis induced
by hourly caerulein administration, pretreatment by dif-
ferent dosages of NaHS (5 mg/kg, 10 mg/kg and 15 mg/
kg) revealed that NaHS 10 mg/kg was associated with
down-regulation of inflammation both in pancreas and
lung and it was accompanied by reduction of pro-inflam-
matory chemokines and adhesion molecules. In addition,
these results have further demonstrated dose dependent
effects of NaHS in inflammation and thus confirm hydro-
gen sulfide as a novel gaseous transmitter that exerts dual
effects in various pathophysiological conditions. Thus, an
H2S-releasing compound, at low doses, may represent a
potential pharmacological approach in the treatment of
inflammation. A lot of research is on going to develop
novel H2S donors and this line of research would, hope-
fully, provide a better solution to fight against the inflam-
matory disorders.
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